Latest News
Breaking news and real-time updates from the ASX small-cap market
NH3 Clean Energy Advances WAH2 Ammonia Project with Positive Environmental Surveys
NH3 Clean Energy reaches milestone as WAH2 surveys detect no threatened flora/fauna, accelerating approvals for its low-emissions ammonia project.
Proteomics International Appoints Healius Exclusive Australian Distributor for Promarker Blood Tests
Proteomics inks exclusive Australian distributor deal with Healius for Promarker blood tests, enabling nationwide rollout by 2027; revenue not yet estimable.
Atturra Maintains Earnings Guidance Despite Revenue Falling Short
Atturra keeps FY26 EBITDA guidance at $30m-$30.5m despite revenue miss; flags $20m-$25m impairment and outlines strong FY27 growth ahead of Aug 26 results.
Amaero Posts Record Quarter on Increased Commercial Demand
Amaero posts record Q426 revenue of A$7.8m (+417% YoY) as backlog hits A$23.1m; eyed US listing after redomiciling, DoW contract boosts demand.
Eden Innovations Achieves Strong Indian Government Concrete Trial Results
Eden Innovations posts strong CRRI lab results for EdenCrete Pz7; fly ash and CNT boost strength and durability, with cement-reduction potential.
TG Metals and Medallion Metals Sign Ore Processing Agreement for Van Uden Gold Stockpiles
TG Metals signs non-binding deal with Medallion Metals to process ~60,000t Van Uden gold stockpiles at Cosmic Boy, unlocking near-term cashflow.
Black Canyon Delivers 41% Manganese Product in Pilot-Scale Testing of Wandanya Ore
Black Canyon hits 41% manganese product in Wandanya pilot DMS tests; 80-82% recoveries, high-grade, bolstering DSO/manganese scoping study prospects.
Radiopharm Theranostics Reports Positive Results from RAD204 and RAD101 Trials
Radiopharm Theranostics reports durable partial response for RAD204 in Phase 1; RAD101 Phase 2b brain mets shows 93% MRI-PET concordance, 86% sensitivity.
Horizon Gold Defines Path to 2028 Production for Gum Creek Project
Horizon Gold maps 2028 Gum Creek gold start after DFS; $350m capex, NPV $1.31b, IRR 53%, FID eyed in 2Q2027.
MONEYME Passes $2 Billion Loan Book with Positive Second-Half Profit
MONEYME passes $2B loan book as FY26 originations hit a record; H2 NPAT positive amid improving credit quality and cost efficiency.
Lumos Diagnostics Expands FebriDx Rollout Across Priority US Urgent Care Accounts
Lumos Diagnostics expands FebriDx rollout to 430 US urgent care sites across top accounts, targeting 2.6 million ARI visits annually—rapid expansion under way.
Optiscan Imaging Advances Head and Neck Cancer Study Ahead of Schedule
Optiscan Imaging pushes Stage 2 of head and neck cancer live-imaging study ahead of schedule, accelerating clinical validation and potential FDA submissions.